Product Code: ETC4537982 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Human Milk Oligosaccharides (HMO) Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 United States (US) Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 United States (US) Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the health benefits of human milk oligosaccharides (HMOs) for infants |
4.2.2 Rising demand for infant formula with added HMOs as a functional ingredient |
4.2.3 Growing focus on infant nutrition and gut health |
4.3 Market Restraints |
4.3.1 High production costs associated with extracting and incorporating HMOs into infant formula |
4.3.2 Regulatory challenges and stringent guidelines for HMO products |
4.3.3 Limited availability of scientific research supporting the long-term benefits of HMOs |
5 United States (US) Human Milk Oligosaccharides (HMO) Market Trends |
6 United States (US) Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 United States (US) Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021 - 2031F |
6.1.4 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021 - 2031F |
6.1.5 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021 - 2031F |
6.1.6 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021 - 2031F |
6.2 United States (US) Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021 - 2031F |
6.2.3 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021 - 2031F |
6.2.4 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021 - 2031F |
6.3 United States (US) Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021 - 2031F |
6.3.3 United States (US) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021 - 2031F |
7 United States (US) Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 United States (US) Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 United States (US) Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 United States (US) Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and development investment in HMO technology and product innovation |
8.2 Adoption rate of infant formula containing HMOs among parents and caregivers |
8.3 Number of clinical trials and studies on the efficacy and safety of HMOs |
8.4 Market penetration of HMO-enhanced infant formula in the United States |
9 United States (US) Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 United States (US) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 United States (US) Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 United States (US) Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |